Abstract
We report two patients who developed serum sickness and leukocytoclastic vasculitis following intra-coronary streptokinase therapy for acute myocardial infarction. Additional experience is needed to establish a relationship between streptokinase and serum sickness, and any adverse impact it may have on management of patients with evolving acute myocardial infarction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 433-438 |
| Number of pages | 6 |
| Journal | Current Therapeutic Research - Clinical and Experimental |
| Volume | 35 |
| Issue number | 3 |
| State | Published - 1984 |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmacology (medical)